Abstract | OBJECTIVES: BACKGROUND: In the setting of primary angioplasty, stent restenosis occurs in up to 27% of patients. The introduction of drug-eluting stents has drastically reduced the incidence of restenosis in clinically stable patients. METHODS: We conducted a randomized trial of 320 patients with acute ST-segment elevation myocardial infarction assigned to receive SES or BMS. The primary end point was binary restenosis at 1-year angiographic follow-up. RESULTS: At 1 year, the incidence of binary restenosis was lower in the SES group than in the BMS group (9.3% vs. 21.3%, respectively; p = 0.032), as were the rates of target lesion revascularization (4.3% vs. 11.2%; p = 0.02), target vessel revascularization (5% vs. 13.1; p = 0.015), major adverse cardiac events (6.8% vs. 16.8%; p = 0.005), and target vessel failure (8.7% vs. 18.7%; p = 0.007). The incidence of angiographically documented stent thrombosis was 1.2% (n = 2) in the SES group and 0.6% (n = 1) in the BMS group. CONCLUSIONS: In patients with acute myocardial infarction, SES are superior to BMS, reducing the incidence of binary restenosis by 56%, target lesion revascularization by 61%, target vessel revascularization by 62%, adverse cardiac events by 59%, and target vessel failure by 53% at 1 year. ( Sirolimus Eluting Stenting in Acute Myocardial Infarction; http://www.clinicaltrials.gov/ct/show/NCT00288210; NCT00288210).
|
Authors | Maurizio Menichelli, Antonio Parma, Edoardo Pucci, Rosario Fiorilli, Francesco De Felice, Marco Nazzaro, Alessia Giulivi, Domenico Alborino, Arianna Azzellino, Roberto Violini |
Journal | Journal of the American College of Cardiology
(J Am Coll Cardiol)
Vol. 49
Issue 19
Pg. 1924-30
(May 15 2007)
ISSN: 1558-3597 [Electronic] United States |
PMID | 17498576
(Publication Type: Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Immunosuppressive Agents
- Sirolimus
|
Topics |
- Aged
- Angioplasty, Balloon, Coronary
- Equipment Design
- Female
- Follow-Up Studies
- Graft Occlusion, Vascular
(epidemiology)
- Humans
- Immunosuppressive Agents
(administration & dosage)
- Incidence
- Male
- Middle Aged
- Myocardial Infarction
(diagnostic imaging, therapy)
- Radiography
- Sirolimus
(administration & dosage)
- Stents
|